AbbVie’s Diversification Bet Gradually Shows Results, While Pfizer Seeks a Second Takeoff Through Its GLP-1 and Oncology Pipelines
TSMC’s Market Share Exceeds 70 Percent, Making It Irreplaceable, and Analysts Believe the Current Pullback Offers a Buying Opportunity
U.S. Treasury Secretary Predicts Crude Oil Will Return to $40–$50, Signaling a Turning Point for Global Bond Markets
